AGREX | GRSRX | AGREX / GRSRX | |
Total Expense Ratio | 1.42 | 1.34 | 106% |
Annual Report Gross Expense Ratio | 1.42 | 1.34 | 106% |
Fund Existence | 20 years | 11 years | - |
Gain YTD | 6.071 | 8.316 | 73% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 135M | 1.99B | 7% |
Annual Yield % from dividends | 2.06 | 2.29 | 90% |
Returns for 1 year | 8.86 | 10.86 | 82% |
Returns for 3 years | -5.08 | 11.19 | -45% |
Returns for 5 years | 0.49 | 30.32 | 2% |
Returns for 10 years | -6.05 | 44.36 | -14% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TCGCX | 21.63 | 0.26 | +1.22% |
Thornburg Small/Mid Cap Growth C | |||
AXVIX | 18.20 | 0.10 | +0.55% |
Acclivity Small Cap Value I | |||
FBTDX | 105.90 | 0.53 | +0.50% |
Franklin Biotechnology Discovery C | |||
HSWTX | 20.81 | 0.04 | +0.19% |
Hartford Schroders International Stk R5 | |||
DIFFX | 12.38 | -0.01 | -0.08% |
MFS Diversified Income R3 |